Y Intercept (Hong Kong) LTD Pacific Biosciences Of California, Inc. Transaction History

Y Intercept (Hong Kong) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$5.97 - $10.36 $457,851 - $794,529	76,692 New	76,692 $752,000
Q2 2023 Aug 14, 2023	SELL	$9.97 - $14.05 $75,223 - $106,007	-7,545 Reduced 12.42%	53,218 $707,000
Q1 2023 May 09, 2023	BUY	$7.94 - $12.02 $482,458 - $730,371	60,763 New	60,763 $703,000
Q2 2021 Aug 12, 2021	SELL	$22.3 - $36.02 $384,808 - $621,561	-17,256 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$26.38 - $51.15 $455,213 - $882,644	17,256 New	17,256 $517,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.